While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a fundamentally human skill.

Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...

The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...

Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.

AI systems are already writing the code used to build better AI. Researchers are now asking whether that feedback loop could produce a system capable of replacing its human builders entirely ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

COPENHAGEN, Denmark, July 16, 2026 /PRNewswire/ -- ATLANT 3D today announced that it has secured an order from a leading global AI hyperscaler for its NANOFABRICATOR® LITE platform. The system will ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

July 2026 AI news reveals rumored specs for Moonshot AI's 2.5 trillion parameter Kimi K3 model amidst reported Google Gemini ...